NM_080473.5:c.981G>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_080473.5(GATA5):c.981G>C(p.Ser327Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.496 in 1,604,128 control chromosomes in the GnomAD database, including 198,932 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.54 ( 22497 hom., cov: 33)
Exomes 𝑓: 0.49 ( 176435 hom. )
Consequence
GATA5
NM_080473.5 synonymous
NM_080473.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.05
Publications
19 publications found
Genes affected
GATA5 (HGNC:15802): (GATA binding protein 5) The protein encoded by this gene is a transcription factor that contains two GATA-type zinc fingers. The encoded protein is known to bind to hepatocyte nuclear factor-1alpha (HNF-1alpha), and this interaction is essential for cooperative activation of the intestinal lactase-phlorizin hydrolase promoter. In other organisms, similar proteins may be involved in the establishment of cardiac smooth muscle cell diversity. [provided by RefSeq, Jul 2008]
GATA5 Gene-Disease associations (from GenCC):
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial bicuspid aortic valveInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- tetralogy of fallotInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital heart defects, multiple types, 5Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 20-62465397-C-G is Benign according to our data. Variant chr20-62465397-C-G is described in ClinVar as Benign. ClinVar VariationId is 1174882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.05 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.662 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GATA5 | ENST00000252997.3 | c.981G>C | p.Ser327Ser | synonymous_variant | Exon 6 of 7 | 1 | NM_080473.5 | ENSP00000252997.2 |
Frequencies
GnomAD3 genomes AF: 0.536 AC: 81325AN: 151754Hom.: 22458 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
81325
AN:
151754
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.486 AC: 118556AN: 243820 AF XY: 0.481 show subpopulations
GnomAD2 exomes
AF:
AC:
118556
AN:
243820
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.491 AC: 713576AN: 1452256Hom.: 176435 Cov.: 44 AF XY: 0.489 AC XY: 353288AN XY: 722564 show subpopulations
GnomAD4 exome
AF:
AC:
713576
AN:
1452256
Hom.:
Cov.:
44
AF XY:
AC XY:
353288
AN XY:
722564
show subpopulations
African (AFR)
AF:
AC:
22405
AN:
33412
American (AMR)
AF:
AC:
20690
AN:
44488
Ashkenazi Jewish (ASJ)
AF:
AC:
10896
AN:
25968
East Asian (EAS)
AF:
AC:
21192
AN:
39548
South Asian (SAS)
AF:
AC:
37401
AN:
86120
European-Finnish (FIN)
AF:
AC:
22747
AN:
47222
Middle Eastern (MID)
AF:
AC:
2426
AN:
5656
European-Non Finnish (NFE)
AF:
AC:
546147
AN:
1109736
Other (OTH)
AF:
AC:
29672
AN:
60106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
18360
36720
55079
73439
91799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
16026
32052
48078
64104
80130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.536 AC: 81421AN: 151872Hom.: 22497 Cov.: 33 AF XY: 0.533 AC XY: 39599AN XY: 74238 show subpopulations
GnomAD4 genome
AF:
AC:
81421
AN:
151872
Hom.:
Cov.:
33
AF XY:
AC XY:
39599
AN XY:
74238
show subpopulations
African (AFR)
AF:
AC:
27743
AN:
41464
American (AMR)
AF:
AC:
7728
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1442
AN:
3468
East Asian (EAS)
AF:
AC:
2518
AN:
5116
South Asian (SAS)
AF:
AC:
2160
AN:
4818
European-Finnish (FIN)
AF:
AC:
4776
AN:
10542
Middle Eastern (MID)
AF:
AC:
142
AN:
290
European-Non Finnish (NFE)
AF:
AC:
33339
AN:
67868
Other (OTH)
AF:
AC:
1121
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1933
3867
5800
7734
9667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1749
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Sep 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Congenital heart defects, multiple types, 5 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.